🇺🇸 FDA
Pipeline program

Descartes 08

DC-08-B

Phase 2 mab terminated

Quick answer

Descartes 08 for Myeloma Multiple is a Phase 2 program (mab) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Myeloma Multiple
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials